Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trial
Abstract Intense intermittent fasting regimens safely reduce weight to a similar extent as caloric restriction. A previous trial reported low-frequency 26-week intermittent fasting reduced homeostatic model assessment of insulin resistance (HOMA-IR) without significant weight loss. During fasting, h...
| Published in: | npj Metabolic Health and Disease |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Online Access: | https://doi.org/10.1038/s44324-024-00025-2 |
